Diffuse Midline Glioma, H3K27-altered
2 clinical trials · Condition
◉ Watch Diffuse Midline Glioma, H3K27-altered
| Record | Firm | Date |
|---|---|---|
| Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion (NCT06333899) | Nationwide Children's Hospital | 2025-08-03 |
| Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 (NCT05476939) | Gustave Roussy, Cancer Campus, Grand Paris | 2022-09-29 |
Track Diffuse Midline Glioma, H3K27-altered automatically
Every clearance here is in the API, with alerts when new ones post.